According to Future Market Insights' most recent industry report, the global automated cell biology systems market stands at US$ 14.1 Billion in 2022 and is expected to rise at a CAGR close to 9.0% over the forecast period, with an anticipated worth of around US$ 33.5 Billion in 2032.
The development of powerful new technologies and applications is made possible by laboratory automation, a major force in the biotechnology sector. Automation in research and production, specifically in the area of personalized therapies, is a requirement for achieving cost effectiveness and widespread accessibility of customized treatments.
Over the last two decades, the biotechnology sector has paid increasingly more attention to laboratory automation. With the development of digitalization and Industry 4.0, biotech automation has spread from its initial focus on analytical laboratories to now being used widely throughout the industry.
In fact, it is widely acknowledged that many aspects of future medicine would only be possible with the help of automation. These include automated complicated data processing for precision medicine, healthcare robotics for surgery and care, automated production, and sophisticated supply chains for innovative therapeutics.
This is especially true for cell-based personalized medicines, which depend on automation to lower costs and increase accessibility. Whether for personalized drug research or autologous cell treatments, patient-derived cell multiplication is labor-intensive and characterized by substantial batch-to-batch variability.
Additionally, because individual batch sizes are small, personalized medicine requires a high overall throughput in order to be economically viable. These factors pose a demand for automated cell biology systems, thus propelling the overall market value over the forecast period.
Market Competition
Key Players:
- Thermo Fisher Scientific
- Corning Incorporated
- Merck KGaA
- Lonza
- Sartorius AG
- Hitachi. Ltd
- Nanoentek
- ChemoMetec
- Danaher corporation
- Others
Read More@ https://www.futuremarketinsights.com/reports/automated-cell-biology-systems-market
Key Market Segments Covered in Automated Cell Biology Systems Industry Research
By Product:
- Cell Culture Process Automatization Instrument or Robot (Multiple Function)
- Automated Bioreactor (Single or Multiple Function)
- Automated Cell Culture Media Exchange System (Single Function)
- Automated Culture Media Analyzer (Single Function)
- Automated Cell Wash-and-Concentrate System (Single Function)
- Automated Cell Counter (Single Function)
- Automated Fill And Finish System (Single Function)
- Automated Cell Storage Equipment (Single Function)
- Management Software
By Cell Culture:
- Finite Cell Line Cultures
- Infinite Cell Line Cultures
By Application:
- Cell Therapy
- Drug Development
- Stem Cell Research
- Regenerative Medicine
By End User:
- Mega Pharmaceutical companies
- Biopharmaceutical companies
- CDMOs/CMOs
- Research organizations
- Academic institutes